发明公开
EP2307426A1 FUSED PYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
审中-公开
炎症性疾病和退行性SUITABLE简明吡嗪的治疗
- 专利标题： FUSED PYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
- 专利标题（中）： 炎症性疾病和退行性SUITABLE简明吡嗪的治疗
-
申请号： EP09742103.6申请日： 2009-05-06
-
公开(公告)号： EP2307426A1公开(公告)日： 2011-04-13
- 发明人: ANDREWS, Martin James Inglis , CHAMBERS, Mark Stuart , VAN DE POËL, Hervé , BAR, Grégory Louis Joseph
- 申请人： Galapagos N.V.
- 申请人地址： Generaal de Wittelaan L11 A3 2800 Mechelen BE
- 专利权人： Galapagos N.V.
- 当前专利权人： Galapagos N.V.
- 当前专利权人地址： Generaal de Wittelaan L11 A3 2800 Mechelen BE
- 代理机构： Nichol, Maria Zenarosa
- 优先权： US126833P 20080507; US145827P 20090120
- 国际公布： WO2009135885 20091112
- 主分类号： C07D519/00
- IPC分类号： C07D519/00 ; A61K31/4985 ; A61K31/4995 ; A61P19/02
摘要：
Novel [1.2.4]triazolo[1,5-a]pyrazine and imidazo[1,2-a]pyrazine compounds are disclosed that have a formula represented by the following: Formula (Ia) or Formula (Ib). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non- limiting example, pain, inflammation, and others.
信息查询
